Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

(2014) Lisa Oestereich et al.   ANTIVIRAL RESEARCH

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

(2014) Gerrit Gehring et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Ebola vaccine: Little and late

(2014) J. Cohen   SCIENCE

Identification of repurposed small molecule drugs for chordoma therapy

(2013) Menghang Xia et al.   CANCER BIOLOGY & THERAPY

The potential of sunitinib as a therapy in ovarian cancer

(2013) Umberto Leone Roberti Maggiore et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides

(2013) G. M. Laird et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection

(2013) Charles J. Shoemaker et al.   PLoS One

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

(2013) Peter B. Madrid et al.   PLoS One

FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection

(2013) L. M. Johansen et al.   Science Translational Medicine

Digoxin Suppresses HIV-1 Replication by Altering Viral RNA Processing

(2013) Raymond W. Wong et al.   PLoS Pathogens

Identification of Small Molecules with Type I Interferon Inducing Properties by High-Throughput Screening

(2012) Luis Martínez-Gil et al.   PLoS One

The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics

(2011) R. Huang et al.   Science Translational Medicine

Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry

(2010) D. Dube et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ebola virus uses clathrin-mediated endocytosis as an entry pathway

(2010) Suchita Bhattacharyya et al.   VIROLOGY

Cardiac Glycosides Inhibit p53 Synthesis by a Mechanism Relieved by Src or MAPK Inhibition

(2009) Z. Wang et al.   CANCER RESEARCH

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition

(2009) Osvaldo Martinez et al.   CELLULAR MICROBIOLOGY

Dronedarone

(2009) Sheridan M. Hoy et al.   DRUGS

An enzymatic virus-like particle assay for sensitive detection of virus entry

(2009) Donna M. Tscherne et al.   JOURNAL OF VIROLOGICAL METHODS